Ajay Gupta

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

Sripal Bangalore, Sunil Kumar, Sverre E. Kjeldsen et al. · The Lancet Oncology · 2010 · 356 citations

Non-pharmacological Intervention, Hypertension, Oncology +15

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

Ajay Gupta, David Thompson, Andrew Whitehouse et al. · The Lancet · 2017 · 333 citations · Full text

Adverse Events, Cardiovascular Disease, Clinical Trials +8

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Kazem Rahimi, Zeinab Bidel, Milad Nazarzadeh et al. · The Lancet · 2021 · 299 citations · Full text

Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT)

Ajay Gupta, Efthimia Nasothimiou, Choon Lan Chang et al. · Journal of Hypertension · 2011 · 162 citations

Determinants of New-Onset Diabetes Among 19,257 Hypertensive Patients Randomized in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm and the Relative Influence of Antihypertensive Medication

Ajay Gupta, Björn Dahlöf, Joanna Dobson et al. · Diabetes Care · 2008 · 147 citations · Full text